While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting ...
Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization.
A clinical trial suggests that low-dose lithium may slow the decline of verbal memory in older adults with mild cognitive impairment and amyloid-beta.
Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results